Cargando…
Hypoxia‐inducible factor 1A inhibition overcomes castration resistance of prostate tumors
Androgen deprivation therapy (ADT) is a cornerstone of prostate cancer (PCa) management. Although tumors initially regress, many progress to a hormone‐independent state termed castration‐resistant PCa (CRPC), for which treatment options are limited. We here report that the major luminal cell populat...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245031/ https://www.ncbi.nlm.nih.gov/pubmed/37070472 http://dx.doi.org/10.15252/emmm.202217209 |